{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:44:33Z","timestamp":1785199473353,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.diabres.2025.112233","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:04:39Z","timestamp":1746533079000},"page":"112233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Paediatric screening in Italy as a gateway to secondary prevention in type 1 diabetes"],"prefix":"10.1016","volume":"224","author":[{"given":"MV.","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zampetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112233_b0005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11892-014-0517-x","article-title":"Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis","volume":"14","author":"Cohn","year":"2014","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.diabres.2025.112233_b0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.diabres.2025.112233_b0015","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.diabres.2025.112233_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MED.0000000000000173","article-title":"General population screening for type 1 diabetes: has its time come?","volume":"22","author":"Insel","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.diabres.2025.112233_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/joim.13648","article-title":"TEDDY Study Group. Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes","volume":"294","author":"Lernmark","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.diabres.2025.112233_b0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1399-5448.2011.00774.x","article-title":"TEDDY Study Group. the environmental determinants of diabetes in the young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants","volume":"12","author":"Hagopian","year":"2011","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.diabres.2025.112233_b0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/db18-0882","article-title":"TEDDY Study Group; Teddy Study Group. Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families","volume":"68","author":"Hippich","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112233_b0040","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/dc23-1947","article-title":"Genes were separately associated with the progression from seroconversion to onset of type 1 diabetes among participants in two diabetes prevention trials (DPT-1 and TN07)","volume":"47","author":"Zhao","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0045","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.112233_b0050","doi-asserted-by":"crossref","unstructured":"E.K. Sims, R.E.J. Besser, C. Dayan, C. Geno Rasmussen, C. Greenbaum, K.J. Griffin, W. Hagopian, M. Knip, A.E. Long, F. Martin, C. Mathieu, M. Rewers, A.K. Steck, J.M. Wentworth, S.S. Rich, O. Kordonouri, A.G. Ziegler, K.C. Herold, NIDDK type 1 diabetes TrialNet Study Group, Screening for type 1 diabetes in the general population: a status report and perspective, Diabetes 71 (2022) 610\u2013623.","DOI":"10.2337\/dbi20-0054"},{"key":"10.1016\/j.diabres.2025.112233_b0055","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diab.45.7.926","article-title":"Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc\/IA-2 autoantibodies","volume":"45","author":"Verge","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.112233_b0060","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type I diabetes mellitus. A chronic autoimmune disease","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2025.112233_b0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.diabres.2025.112233_b0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-22-0025","article-title":"Shared etiology of type 1 diabetes and Hashimoto's thyroiditis: a population-based twin study","volume":"186","author":"Skov","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.diabres.2025.112233_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102405","article-title":"Co-existence of type 1 diabetes and other autoimmune ailments in subjects with autoimmune thyroid disorders","volume":"16","author":"Sharma","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.diabres.2025.112233_b0080","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00125-023-05953-0","article-title":"Fr1da Study Group. Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation","volume":"66","author":"Hummel","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112233_b0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00125-013-2960-7","article-title":"The use of intermediate endpoints in the design of type 1 diabetes prevention trials","volume":"56","author":"Skyler","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112233_b0090","first-page":"2603","article-title":"The pathogenesis and natural history of type 1 diabetes","volume":"37","author":"Atkinson","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0095","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.112233_b0100","unstructured":"American Diabetes Association Professional Practice Committee; 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142024.Diabetes Care1 January 2024; 47 (Supplement_1): S20\u2013S42."},{"key":"10.1016\/j.diabres.2025.112233_b0105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/dc19-0315","article-title":"Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes","volume":"42","author":"Winkler","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.abi4742","article-title":"Preventing type 1 diabetes in childhood","volume":"373","author":"Dayan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.diabres.2025.112233_b0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2025.112233_b0120","first-page":"S27","article-title":"Standards of Care in Diabetes\u20142025","volume":"48","author":"Diagnosis and Classification of Diabetes","year":"2025","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2025.112233_b0125","article-title":"Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth","volume":"15","author":"Skyler","year":"2013","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.diabres.2025.112233_b0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/bmb\/ldab027","article-title":"Immunotherapy for type 1 diabetes","volume":"140","author":"Allen","year":"2021","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.diabres.2025.112233_b0135","doi-asserted-by":"crossref","unstructured":"L.M. Jacobsen, J.L. Felton, B.M. Nathan, C. Speake, J. Krischer, K.C. Herold, Type1DiabetesTrialNet: Leading the Charge in Disease Prediction,Prevention, and Immunotherapeutic Mechanistic Understanding. Diabetes Care 2025 Apr 24:dc242908.","DOI":"10.2337\/dc24-2908"},{"key":"10.1016\/j.diabres.2025.112233_b0140","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"PROTECT study investigators. Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2025.112233_b0145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.2337\/dc23-0675","article-title":"Teplizumab: A disease-modifying therapy for type 1 diabetes that preserves \u03b2-cell function","volume":"46","author":"Herold","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0150","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00125-019-05047-w","article-title":"The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening","volume":"63","author":"Jacobsen","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112233_b0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.diabres.2025.112233_b0160","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00125-018-4726-8","article-title":"Immunological biomarkers for the development and progression of type 1 diabetes","volume":"61","author":"Mathieu","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2025.112233_b0165","doi-asserted-by":"crossref","first-page":"e3749","DOI":"10.1002\/dmrr.3749","article-title":"Garc\u00eda-Hermoso A Incidence of type 1 diabetes mellitus in children and adolescents under 20years of age across 55 countries from 2000 to 2022: A systematic review with meta-analysis","volume":"40","author":"Hormaz\u00e1bal-Aguayo","year":"2024","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.diabres.2025.112233_b0170","article-title":"Gene-environmentinteractionin thepathophysiologyoftype1diabetes","volume":"15","author":"Mittal","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2025.112233_b0175","doi-asserted-by":"crossref","unstructured":"Emily K. Sims, Rachel E.J. Besser, Colin Dayan, Cristy Geno Rasmussen, Carla Greenbaum, Kurt J. Griffin, William Hagopian, Mikael Knip, Anna E. Long, Frank Martin, Chantal Mathieu, Marian Rewers, Andrea K. Steck, John M. Wentworth, Stephen S. Rich, Olga Kordonouri, Anette-Gabriele Ziegler, Kevan C. Herold; NIDDK Type 1 Diabetes TrialNet Study Group. Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective Diabetes 2022;71:610-623.","DOI":"10.2337\/dbi20-0054"},{"key":"10.1016\/j.diabres.2025.112233_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111750","article-title":"Incidence of type 1 diabetes in Sardinian children aged 0\u201314 years has almost doubled in the last twenty years. On top of the world","volume":"213","author":"Ripoli","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.diabres.2025.112233_b0185","doi-asserted-by":"crossref","unstructured":"E. Bosi, C. Catassi, Screening type 1 diabetes and celiac disease by law Lancet Diabetes Endocrinol 12 (2024) 12-14.","DOI":"10.1016\/S2213-8587(23)00354-6"},{"key":"10.1016\/j.diabres.2025.112233_b0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13052-023-01438-3","volume":"19","author":"Cherubini","year":"2023","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.diabres.2025.112233_b0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3399\/bjgp23X731709","article-title":"Screening children for presymptomatic type 1 diabetes","volume":"73","author":"Quinn","year":"2022","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.diabres.2025.112233_b0200","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc17-0558","article-title":"Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts po, Wan or long-term glycemic control","volume":"40","author":"Duca","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101603","article-title":"Screening and care for preclinical stage 1-2 type 1 diabetes in first-degree relatives: French expert position statement","volume":"51","author":"Mallone","year":"2025","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.diabres.2025.112233_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088522","article-title":"EDENT1FI consortium EDENT1FI Master Protocol forscreeningof presymptomaticearly-stagetype1diabetesinchildrenand adolescents","volume":"15","author":"Hoffmann","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabres.2025.112233_b0215","doi-asserted-by":"crossref","first-page":"38844","DOI":"10.1038\/srep38844","article-title":"High frequency of diabetic ketoacidosis at diagnosis of type 1 diabetes in Italian children: a nationwide longitudinal study, 2004\u20132013","volume":"6","author":"Cherubini","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.diabres.2025.112233_b0220","first-page":"17","article-title":"When is screening for type 1 diabetes in children justified?","volume":"2","author":"Ludvigsson","year":"2021","journal-title":"J. Pediatr. Neonatol."},{"key":"10.1016\/j.diabres.2025.112233_b0225","first-page":"387","article-title":"A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8)","volume":"6","author":"Pozzilli","year":"2004","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.diabres.2025.112233_b0230","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1111\/dom.15213","article-title":"IMDIAB study group. Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study","volume":"25","author":"Maddaloni","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.diabres.2025.112233_b0235","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2337\/dc11-1026","article-title":"Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up","volume":"34","author":"Elding Larsson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0240","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/pedi.12674","article-title":"Family adjustment to diabetes diagnosis in children: can participation in a study on type 1 diabetes genetic risk be helpful?","volume":"19","author":"Smith","year":"2017","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.diabres.2025.112233_b0245","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2337\/dci23-0061","article-title":"General population screening for islet autoantibodies: psychosocial challenges","volume":"46","author":"Johnson","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112233_b0250","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1111\/dom.15779","article-title":"Follow-up and monitoring programme in children identified in early-stage type 1 diabetes during screening in the general population of Italy","volume":"26","author":"Cherubini","year":"2024","journal-title":"Diabetes Obes. Metab."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725002475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:51:23Z","timestamp":1778388683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725002475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S0168822725002475"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112233","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paediatric screening in Italy as a gateway to secondary prevention in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112233"}}